focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenedrive Share News (GDR)

Share Price Information for Genedrive (GDR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.65
Bid: 1.60
Ask: 1.70
Change: 0.00 (0.00%)
Spread: 0.10 (6.25%)
Open: 1.65
High: 1.65
Low: 1.65
Prev. Close: 1.65
GDR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Zytronic hit by electronic component shortages

Thu, 09th Feb 2023 11:19

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

----------

AIM - WINNERS

----------

Genedrive PLC, up 34% at 33.47 pence, 12-month range 8p-42p. The molecular diagnostics company says the UK's National Institute for Health & Care Excellence has preliminarily recommended its antiobiotic-induced hearing loss test for use in the National Health Service. NICE's final guidance will follow a public consultation period, which will close on February 21. "We encourage relevant stakeholders to participate during the public consultation period to support our pioneering work, and look forward to receiving the final NICE report," says CEO David Budd.

----------

Shield Therapeutics PLC, up 12% at 6.9p, 12-month range 5.5p-36p. The commercial stage pharmaceutical company updates on its annual performance, and now expects revenue of GBP8.5 million, multiplied year-on-year from GBP1.5 million. Says the period was a "landmark" year for Accrufer, its novel oral iron therapy. CEO Greg Madison notes its sales collobration with Viatris is "off to a great start".

----------

AIM - LOSERS

----------

Zytronic PLC, down 11% at 134p, 12-month range 110p-192.49p. The touch sensors manufacturer says the performance in the first four months of its financial year has been hit by ongoing global supply chain issues, leading to a shortage of some electronic components. Consequently, it has needed to buy some of these at a higher price on the "grey market", or cannibalise its existing stock. Also notes potential rising costs from proposed increases to national minimum wage and nation living wage in the UK, as well as wage negotiations with its employee representatives. It now expects revenue to be more weighted towards the second half than in the previous year.

----------

Beowulf Mining PLC, down 8.0% at 3p, 12-month range 2.38p-22.2p. The mining company launches a retail offer of up to 104.0 million new shares at 2.06p, which is around a 31% discount to its closing price on Wednesday. It plans to raise around GBP2.1 million in gross proceeds, which it will put towards its workstreams. Also conducts a preferential rights issue of up to 316.7 million Swedish depositary receipts to raise around GBP6.8 million.

----------

By Elizabeth Winter, Alliance News senior markets reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
31 Aug 2021 12:05

Genedrive to seek CE mark clearance for MT-RNR1 assay

(Sharecast News) - Molecular diagnostics company Genedrive said on Tuesday that it will soon launch its MT-RNR1 assay, used for the detection of antibiotic-induced hearing loss in newborns.

Read more
1 Jul 2021 19:26

TRADING UPDATES: Gym Group bulks up with placing; 88 Energy debt free

TRADING UPDATES: Gym Group bulks up with placing; 88 Energy debt free

Read more
1 Jul 2021 09:52

Genedrive makes progress with Covid-19 test development

(Sharecast News) - Molecular diagnostics company Genedrive updated the market on the development of its 'COV19-ID Kit', a rapid point-of-care molecular test for SARS-CoV-2 detection designed for its 'Genedrive instrument', on Thursday.

Read more
25 Jun 2021 14:39

IN BRIEF: Genedrive receives Indian import license for Covid test kit

IN BRIEF: Genedrive receives Indian import license for Covid test kit

Read more
30 Apr 2021 13:16

Genedrive Covid-19 test formally approved in India

(Sharecast News) - Molecular diagnostics company Genedrive announced on Friday that the 'Genedrive 96' SARS-CoV-2 kit had been formally approved by the Indian Council of Medical Research (ICMR).

Read more
30 Apr 2021 10:51

Genedrive shares surge after Covid test approved by Indian regulator

Genedrive shares surge after Covid test approved by Indian regulator

Read more
30 Apr 2021 10:40

AIM WINNERS & LOSERS: Hurricane Energy warns of "significant dilution"

AIM WINNERS & LOSERS: Hurricane Energy warns of "significant dilution"

Read more
23 Apr 2021 10:02

Genedrive says study shows kit is effective at diagnosing Hepatitis C

Genedrive says study shows kit is effective at diagnosing Hepatitis C

Read more
19 Apr 2021 14:10

UPDATE: Yourgene wins further national framework contract award

UPDATE: Yourgene wins further national framework contract award

Read more
19 Apr 2021 12:46

IN BRIEF: Genedrive included in Public Health England framework

IN BRIEF: Genedrive included in Public Health England framework

Read more
19 Apr 2021 12:07

Genedrive appointed to PHE microbiology supply framework

(Sharecast News) - Molecular diagnostics company Genedrive has been successful with its tender to Public Health England (PHE) under Lot 1 of the National Microbiology Framework for diagnostic goods and services, it announced on Monday.

Read more
19 Apr 2021 11:44

Yourgene wins national contract award for Covid-19 testing services

Yourgene wins national contract award for Covid-19 testing services

Read more
19 Apr 2021 11:32

AIM WINNERS & LOSERS: Pantheon falls after Alaska drilling results

AIM WINNERS & LOSERS: Pantheon falls after Alaska drilling results

Read more
25 Mar 2021 14:49

TRADING UPDATES: Safestyle in strong start to 2021; Tandem ups payout

TRADING UPDATES: Safestyle in strong start to 2021; Tandem ups payout

Read more
25 Mar 2021 11:28

AIM WINNERS & LOSERS: Tandem rises on strong results, positive outlook

AIM WINNERS & LOSERS: Tandem rises on strong results, positive outlook

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.